Moderna has revealed that it is confident that vaccines for cancer, cardiovascular and autoimmune diseases, and other health conditions will be ready by 2030.
Also, studies into these vaccinations are showing “tremendous promise”, with some researchers revealing 15 years’ worth of progress has been “unspooled” in 12 to 18 months owing to the success of the COVID jab.
Dr Paul Burton, the Chief Medical Officer of Moderna, said he feels the company would be able to offer such treatments for “all sorts of disease areas” in five years.
Moderna, the creator of a leading coronavirus vaccine, is developing cancer vaccines which target different tumour types.
Burton said: “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives. I think we will be able to offer personalized cancer vaccines against multiple different tumour types to people around the world.”
Also, he said that multiple respiratory infections could be covered by a single injection – giving vulnerable people protection against Covid, flu and respiratory syncytial virus (RSV) – while mRNA therapies could be available for uncommon diseases which have no drugs currently.
Burton said: “I think we will have mRNA-based therapies for rare diseases that were previously undruggable, and I think that 10 years from now, we will be approaching a world where you truly can identify the genetic cause of a disease and, with relative simplicity, go and edit that out and repair it using mRNA-based technology.”
SUPPORT NIGERIAN CANADIAN NEWSPAPER CANADA
If you like our work and want to keep enjoying what we offer, kindly support us by donating to the Nigerian Canadian News through the button below
Share your thoughts in the comments section belowDo you want to share any news or information with us? If yes, contact the publisher at publisher@test1.nascitest.club
